Discovery and Chemical Development of the Use-Dependent Sodium Channel Blocker Vixotrigine for the Treatment of Pain

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Case Studies from the Pharmaceutical Industry. Describing the continuum from discovery to development, readers will learn how recent drugs, including grazoprevir, melflufen, relebactam, and tesirine, were developed. This work highlights emerging concepts, new developments, and challenges during the discovery process. Well-known authors from the pharmaceutical industry provide an inside look to traditionally closed-door procedures. Chemists in industry and academia alike will find these accounts valuable.

Cite

CITATION STYLE

APA

Witty, D. R., MacPherson, D. T., Giblin, G. M. P., Williams, M. T., Chen, R., Couming, V., … Osei-Yeboah, F. (2020). Discovery and Chemical Development of the Use-Dependent Sodium Channel Blocker Vixotrigine for the Treatment of Pain. In ACS Symposium Series (Vol. 1369, pp. 1–42). American Chemical Society. https://doi.org/10.1021/bk-2020-1369.ch001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free